Snowball logo
logo
ADYX

Adynxx Inc

ADYX • PINK
$0.0001$0.00  (0%)
Estimate
Beta
-44.599
About the company
Ticker
ADYX
ISIN
US00784D1037
Country
United States of America
Sector (GICS)
Healthcare
Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

Frequently asked questions

What sector does Adynxx Inc (ADYX) operate in?

Adynxx Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Adynxx Inc (ADYX) current stock price?

As of the latest data, Adynxx Inc stock price is $0.00, with a previous close of $0.00.

What is Adynxx Inc (ADYX) current market capitalization?

Adynxx Inc market cap is approximately 580.79.

Does Adynxx Inc (ADYX) pay dividends?

No. Adynxx Inc does not pay a dividend.

What is Adynxx Inc (ADYX) beta (volatility) score?

Adynxx Inc has a beta of -44.599, indicating lower volatility than the overall market.